| Ms Sharon Kiely Howard, APRN CNS BC | |
|
900 6th St Sw, Suite #2, Great Falls, MT 59404-3207 | |
| (406) 727-3242 | |
| (406) 727-3161 |
| Full Name | Ms Sharon Kiely Howard |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Community Health/public Health |
| Location | 900 6th St Sw, Great Falls, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568630994 | NPI | - | NPPES |
| 9972319 | Medicaid | MT | |
| 011002498 | Other | MT | PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SC1501X | Clinical Nurse Specialist - Community Health/public Health | 10355 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Sharon Kiely Howard, APRN CNS BC 900 6th St Sw, Suite #2, Great Falls, MT 59404-3207 Ph: (406) 727-3242 | Ms Sharon Kiely Howard, APRN CNS BC 900 6th St Sw, Suite #2, Great Falls, MT 59404-3207 Ph: (406) 727-3242 |
News Archive
YM BioSciences Inc., is presenting posters on its JAK1/2 inhibiting small molecule (CYT387) and on its novel vascular disrupting agent (CYT997) at the Lorne Cancer Conference in Lorne, Victoria, Australia. CYT387 is an oral JAK1/2 inhibitor, originating from the seminal discovery of JAK1 and JAK2 kinases by Dr. Andrew Wilks, the founder of Cytopia Limited, now YM Australia. CYT997 is an orally-available agent with dual mechanisms of vascular disruption and cytotoxicity and has the potential to be broadly active against a range of tumor types.
The Gambia, Minister of Health Dr. Mariatou Jallow administered the first dose of the pneumococcal vaccine to Gambian children at a rural clinic outside Banjul today. Joined by the Gambia's Vice President, Mrs. Isatou Njie-Saidy, Dr. Jallow and hundreds of Gambian citizens celebrated this historic event, which marks the first step in the rollout of the Gambia's national pneumococcal immunisation programme.
Researchers from the University of Copenhagen and the Technical University of Denmark along with other collaborators in Denmark and the US found that the bacterium Pseudomonas aeruginosa can 'switch on' production of molecules that kill white blood cells - preventing the bacteria being eliminated by the body's immune system.
Universal Detection Technology (www.udetection.com), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, responded today to a bipartisan congressional committee's scathing report card failing the U.S. Government for adequately preparing the country for the threat of a bioterrorism attack.
Results from the study shows that drug, memantine, is no better than a dummy pill when it comes to ameliorating disease symptoms, including the decline of mental abilities and also helping patients with moderate Alzheimer's, the researchers say. Sold under the brand Namenda by Forest Laboratories Inc and Germany's Merz Pharma, the drug had U.S. sales of about $1.2 billion last year.
› Verified 9 days ago
Amanda H Lucas, CNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1101 26th St S, Great Falls, MT 59405 Phone: 406-731-8888 Fax: 406-731-8318 |